OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources

Recursos de NCI

 
NCI CANCERLIT® Search: Hereditary Melanoma - October 2001
Aberrant expression of MSG1 transcriptional activator in human malignant melanoma in vivo. Gene regulation in melanoma progression by the AP-2 transcription factor. Deletion mutants of human deoxycytidine kinase mRNA in cells resistant ...
NCI CANCERLIT® Search: Hereditary Melanoma - September 2001
Table of ContentsQuantitative estimation of chromosome aberration frequency in cancer patients induced by endogenous and exogenous factors.[Genetic alterations in the differential diagnosis of melanocytic diseases]Familial uveal melanoma:...
NCI CANCERLIT® Search: Intraocular Melanoma - October 2001
Occurrence of retinoblastoma and uveal melanoma in the same patient. Occurrence of retinoblastoma and uveal melanoma in the same period. Two cases of primary malignant melanoma of the lacrimal sac. Expression of P53 protein in primary uveal...
NCI CANCERLIT® Search: Intraocular Melanoma - September 2001
Table of ContentsFamilial uveal melanoma: report on three sibling cases.Rapid response to radiation of choroidal melanoma.Indocyanine green angiograms of choroidal nevi. comparison between confocal and nonconfocal scanning laser ophthalmoscope...
NCI CANCERLIT® Search: Therapy of Melanoma - October 2001
Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study. Primary anorectal malignant melanoma: clinical features and results of surgical therapy in Singapore--a case series. Stemming the tide....
NCI CANCERLIT® Search: Therapy of Melanoma - September 2001
Table of ContentsSkin cancer prevention.The European Society of Skin Cancer Prevention--EUROSKIN: towards the promotion and harmonization of skin cancer prevention in Europe. Recommendations.Interferon gamma induction in human melanoma...
NCI CANCERLIT® Search: Hereditary Melanoma - April 2002
Familial multiple myeloma: a family study and review of the literature. p16(Ink4a) in melanocyte senescence and differentiation. Determinants of melanoma in a case-control study of twins (United States). Fluorescence in situ detection of human...
NCI CANCERLIT® Search: Hereditary Melanoma - August 2002
Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector. Physical properties and in vitro transfection efficiency of gene delivery vectors based on complexes of DNA with synthetic...
NCI CANCERLIT® Search: Hereditary Melanoma - February 2002
Gene therapy. Safer and virus-free? Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple...
NCI CANCERLIT® Search: Hereditary Melanoma - January 2002
Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase. The Asp84Glu variant of the MC1R gene in Norwegian melanoma patients. Tumor regression induced by intratumoral injection of DNA coding for ...
NCI CANCERLIT® Search: Hereditary Melanoma - July 2002
Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours. A cluster region of AP-1 responsive elements is required for transcriptional activity of mouse ODC gene by hepatocyte growth factor. p16(Ink4a) in...
NCI CANCERLIT® Search: Hereditary Melanoma - June 2002
Re: DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. Quantitative nested real-time RT-PCR specific for tyrosinase transcripts to quantitate minimal residual disease. Emerging...
NCI CANCERLIT® Search: Hereditary Melanoma - March 2002
Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. DNA repair, dysplastic nevi, and sunlight sensitivity in the...
NCI CANCERLIT® Search: Hereditary Melanoma - May 2002
The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Expression profiling of MMA-1a and splice variant MMA-1b: new cancer/testis antigens identified in human melanoma. Loss of...
NCI CANCERLIT® Search: Hereditary Melanoma - October 2002
Association between functional polymorphism in EGF gene and malignant melanoma. Effective local control of malignant melanoma by intratumoural injection of a beta-emitting radionuclide. Etiology and prevention of melanoma. Functional...
NCI CANCERLIT® Search: Hereditary Melanoma - September 2002
Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines. A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF. DNA mismatch repair enzyme hMSH2 in malignant melanoma:...
NCI CANCERLIT® Search: Intraocular Melanoma - April 2002
Choroidal melanoma in a black patient with oculodermal melanocytosis. Choroidal melanoma treated with cryotherapy. Cryotherapy as a primary treatment for choroidal melanoma. Melanoma-stroma interactions: structural and functional aspects. A unique...
NCI CANCERLIT® Search: Intraocular Melanoma - August 2002
Persistent intraschisis hemorrhage simulating choroidal melanoma. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines. Incidence...
NCI CANCERLIT® Search: Intraocular Melanoma - February 2002
Inflamed juvenile conjunctival naevus: clinicopathological characterisation. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias. Ptois as presenting sign of metastatic...
NCI CANCERLIT® Search: Intraocular Melanoma - January 2002
[Posterior uveal pseudomelanoma. Clinical differential diagnosis at the referral hospital] [Melanoma of the eyelid margin: clinical management and oncopathologic study] Uveal melanomas. Conservation treatment. Color Doppler imaging of...
NCI CANCERLIT® Search: Intraocular Melanoma - July 2002
Management of posterior uveal melanoma: past, present, future. Clinical features of small choroidal melanoma. Cadherin expression in uveal melanoma. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor...
NCI CANCERLIT® Search: Intraocular Melanoma - June 2002
The effect of transpupillary thermotherapy on the human macula. The COMS: why was it not stopped sooner? Imaging to detect metastases from malignant uveal melanoma. [Choroidal melanoma: current therapeutic approaches] [Advantages of digital...
NCI CANCERLIT® Search: Intraocular Melanoma - March 2002
Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Conjunctival melanoma. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Prevalence of the BRCA2 6174 del T mutation...
NCI CANCERLIT® Search: Intraocular Melanoma - May 2002
[Corneal neural paralysis after block excision including the 3 and 9 o'clock meridian] [The Munich/San Diego/Iowa City Collaboration (MuSIC). MuSIC Report I: Design , characteristics of the collective and preliminary results] Sentinel...
NCI CANCERLIT® Search: Intraocular Melanoma - October 2002
Things that go bump in the light. The differential diagnosis of posterior uveal melanomas. Palliative vitrectomy for intraocular metastasis from cutaneous melanoma. Uveal melanoma, hormonal and reproductive factors in women. An...
NCI CANCERLIT® Search: Intraocular Melanoma - September 2002
Cardiac metastasis from uveal melanoma. [Management of small choroidal melanocytic tumors] Metastatic ocular melanoma to the left ventricle inducing near-syncope attacks in an 84-year-old woman. Melanocytoma of the choroid: angiographic and...
NCI CANCERLIT® Search: Therapy of Melanoma - April 2002
Melanoma. Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma. UK guidelines for the management of cutaneous melanoma. Comparison of apoptotic, necrotic and clonogenic cell death...
NCI CANCERLIT® Search: Therapy of Melanoma - August 2002
Delcath Systems' phase III trial for inoperable cancer is planned at Sydney Melanoma Unit. Malignant melanoma: treatments emerging, but early detection is still key. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes ...
NCI CANCERLIT® Search: Therapy of Melanoma - February 2002
[Biotherapy and biochemotherapy of patients with malignant melanoma] Cutaneous melanoma and the Mosan Study Group of pigmented tumors. A step forward to trace invisible skin cancers and to offer better treatments. Management of high-risk...
NCI CANCERLIT® Search: Therapy of Melanoma - January 2002
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. Adjuvant therapy of melanoma: at what cost? Screening for skin cancer: recommendations and rationale. Screening for skin cancer....
NCI CANCERLIT® Search: Therapy of Melanoma - July 2002
European approach to the treatment of malignant melanoma. The role of surgery for patients with metastatic melanoma. Bibliography. Current world literature. Melanoma and other skin neoplasms. Malignant melanoma. Hypopigmentation associated...
NCI CANCERLIT® Search: Therapy of Melanoma - June 2002
Endocrinologic changes in male patients with melanoma during interferon alfa-2b therapy. Phase II trial of Paclitaxel and Dacarbazine with filgrastim administration in advanced malignant melanoma. Biochemotherapy for advanced melanoma:...
NCI CANCERLIT® Search: Therapy of Melanoma - March 2002
Sunscreen use and duration of sun exposure: a double-blind, randomized trial. Targeting the ATF-1/CREB transcription factors by single chain Fv fragment in human melanoma: potential modality for cancer therapy. Impaired platelet...
NCI CANCERLIT® Search: Therapy of Melanoma - May 2002
Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of...
NCI CANCERLIT® Search: Therapy of Melanoma - October 2002
Etiology and prevention of melanoma. Commentary: self interest is not the sole legitimate basis for making decisions. Interferon alfa-2a for melanoma metastases. Interferon as adjuvant treatment for melanoma. Response rates of patients with...
NCI CANCERLIT® Search: Therapy of Melanoma - September 2002
Angiogenic and immune parameters during recombinant interferon-alpha2b adjuvant treatment in patients with melanoma. Surgical techniques of melanoma and sentinel node biopsy. Mohs micrographically controlled surgery and the treatment of...
NCI/PDQ® Health professionals: Intraocular (Uveal) Melanoma Treatment (PDQ®)
TABLE OF CONTENTS General Information About Intraocular (Uveal) Melanoma TreatmentIncidence and MortalityAnatomic LocationDiagnosisPrognostic FactorsCellular Classification of Intraocular (Uveal) MelanomaClassification and Stage Information for...
NCI/PDQ® Health professionals: Melanoma Treatment (PDQ®)
TABLE OF CONTENTS General Information About Melanoma Incidence and MortalityRelated SummariesCellular and Molecular Classification of Melanoma Stage Information for Melanoma Clark Classification (Level of Invasion)Definitions of TNMTreatment Option...
NCI/PDQ® Health professionals: Merkel Cell Carcinoma Treatment (PDQ®)
TABLE OF CONTENTS General Information About Merkel Cell CarcinomaEpidemiology/EtiologyClinical PresentationInitial Clinical EvaluationInitial Staging ResultsClinical ProgressionPotential Prognostic FactorsPrognosisCellular Classification of Merkel...
NCI/PDQ® Health professionals: Skin Cancer Prevention (PDQ®)
TABLE OF CONTENTS Who is at Risk?Factors Associated With an Increased Risk of Nonmelanoma Skin CancerSun and ultraviolet (UV) radiation exposureFactors Associated With an Increased Risk of MelanomaSun and UV radiation exposureInterventions With...
NCI/PDQ® Pacientes: Carcinoma de células de Merkel
TABLE OF CONTENTS Descripción¿Qué es el carcinoma de células de Merkel?Explicación de los estadiosEstadios del carcinoma de células de MerkelEstadio IEstadio IIEstadio IIIRecurrenteAspectos generales de las opciones de...
NCI/PDQ® Pacientes: Melanoma intraocular (relativo al ojo)
TABLE OF CONTENTS Descripción¿Qué es el melanoma intraocular?Explicación de las estadiosEstadios del melanoma intraocularMelanoma del irisMelanoma de cuerpo ciliarMelanoma coroides pequeíoMelanoma coroide mediano y...
NCI/PDQ® Pacientes: Melanoma: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el melanoma Estadios del melanoma Melanoma recidivanteAspectos generales de las opciones de tratamiento Opciones de tratamiento por estadio Estadio 0 (melanoma in situ)Melanoma en estadio IMelanoma en...
NCI/PDQ® Patients: Intraocular (Eye) Melanoma
TABLE OF CONTENTS DescriptionWhat is intraocular melanoma?Stage ExplanationStages of intraocular melanomaIris melanomaCiliary body melanomaSmall choroidal melanomaMedium and large choroidal melanomaExtraocular extension and metastatic intraocular...
NCI/PDQ® Patients: Melanoma Treatment (PDQ®)
TABLE OF CONTENTS General Information About MelanomaStages of MelanomaRecurrent MelanomaTreatment Option OverviewTreatment Options by Stage Stage 0 (Melanoma in Situ)Stage I MelanomaStage II MelanomaStage III MelanomaStage IV and Recurrent...
NCI/PDQ® Patients: Merkel Cell Carcinoma
TABLE OF CONTENTS DescriptionWhat is Merkel cell carcinoma?Stage ExplanationStages of Merkel cell carcinomaStage IStage IIStage IIIRecurrentTreatment Option OverviewHow Merkel cell carcinoma is treatedStage I Merkel Cell CarcinomaStage II Merkel...
NCI/PDQ® Profesionales De Salud: Carcinoma de células de Merkel: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el carcinoma de células de MerkelEpidemiología y etiologíaPresentación clínicaEvaluación clínica inicialResultados de la estadificación inicialEvolución...
NCI/PDQ® Profesionales De Salud: Melanoma ocular uveal: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el tratamiento del melanoma ocular uveal Incidencia y mortalidadLocalización anatómicaDiagnósticoFactores pronósticosEnsayos clínicos en cursoClasificación celular del...
NCI/PDQ® Profesionales De Salud: Melanoma: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el melanomaIncidencia y mortalidadSumarios relacionadosClasificación celular y molecular del melanomaInformación sobre los estadios del melanomaClasificación de Clark (nivel de...
OncoLink I wish u knew...

Dr. O'Dwyer discusses the role of genetics in cancer research and care. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS